BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18543037)

  • 1. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
    Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
    Schuhmacher CP; Fink U; Becker K; Busch R; Dittler HJ; Mueller J; Siewert JR
    Cancer; 2001 Mar; 91(5):918-27. PubMed ID: 11251943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer.
    D'Ugo D; Persiani R; Rausei S; Biondi A; Vigorita V; Boccia S; Ricci R
    Eur J Surg Oncol; 2006 Dec; 32(10):1105-9. PubMed ID: 16930932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer.
    Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A
    Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoadjuvant chemotherapy for locally advanced gastric cancer].
    Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E
    Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
    Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer.
    Cheong JH; Shen JY; Song CS; Hyung WJ; Shen JG; Choi SH; Noh SH
    Ann Surg Oncol; 2007 Jan; 14(1):61-8. PubMed ID: 17058123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.
    Ajani JA; Mansfield PF; Janjan N; Morris J; Pisters PW; Lynch PM; Feig B; Myerson R; Nivers R; Cohen DS; Gunderson LL
    J Clin Oncol; 2004 Jul; 22(14):2774-80. PubMed ID: 15254045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
    Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
    Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601.
    Findlay M; Storey D; Gebski V; Hargreaves C; Cullingford G; Boyer M; Trotter J; Archer S; Davidson A; Johnston P; Yuen J; Dhillon H; Della-Fiorentina S; Richardson G; Truskett P; Goldstein D;
    ANZ J Surg; 2007 Apr; 77(4):247-52. PubMed ID: 17388828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant chemotherapy in gastric carcinoma].
    D'Ugo D; Persiani R; Pende V; Picciocchi A
    Ann Ital Chir; 2001; 72(1):47-53. PubMed ID: 11464495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
    J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
    Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
    Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The German EORTC Study of neoadjuvant therapy of stomach carcinoma].
    Siewert JR; Schuhmacher C; Fink U
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():717-9. PubMed ID: 9931709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
    Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
    J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
    Becker K; Mueller JD; Schulmacher C; Ott K; Fink U; Busch R; Böttcher K; Siewert JR; Höfler H
    Cancer; 2003 Oct; 98(7):1521-30. PubMed ID: 14508841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.